X |
Form
10-KSB |
Form
20-F |
Form
11-K |
Form
10-QSB |
Form
N-SAR |
Transition
Report on Form 10K | |
Transition
Report on Form 20F | |
Transition
Report on Form 11K | |
Transition
Report on Form 10Q | |
Transition
Report on Form NSAR |
Full
name of Registrant: |
ProtoKinetix,
Inc. |
Former
name if Applicable: |
|
Address
of Principal Executive Office (Street and Number): |
Suite
1500-885 West Georgia Street |
City,
State and Zip Code: |
Vancouver,
BC Canada V6C 3E8 |
(a) |
The
reasons described in detail in Part III of this form could not be
eliminated without unreasonable effort or expense; | |
X |
(b) |
The
subject annual report, semi-annual report, transition report of Forms
10-K, 10-KSB, 20-F, 11-K or Form N-SAR, or portion thereof will be filed
on or before the 15th calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q, 10-QSB, or
portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and |
(c) |
The
accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable. |
The
subject report to be filed on Form 10-KSB could not be completed without
unreasonable effort or expense. Delays in gathering relevant data required
in the filing have caused this report to be
filed. |
(1) |
Name
and telephone number of person to contact in regard to this
notification: |
Mark
L. Baum |
760 |
230-2300
extension 205 |
(Name) |
(Area
Code) |
(Telephone
Number) |
(2) |
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been filed?
|
(3) |
Is
it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof? |
Date: |
March
31, 2005 |
By: |
/s/
Dr. John Todd |
Title: |
Chairman
and CEO |